Open-label dose-escalation study of oral 1-octanol in patients with essential tremor

被引:38
作者
Shill, HA
Bushara, KO
Mari, Z
Reich, M
Hallett, M
机构
[1] NINDS, Human Motor Control Sect, Med Neurol Branch, NIH, Bethesda, MD 20892 USA
[2] Minneapolis Vet Affairs Med Ctr, Minneapolis, MN USA
关键词
D O I
10.1212/WNL.62.12.2320
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Twenty-one single oral doses of 1-octanol were given to patients with essential tremor ( ET) in an open-label dose-escalation study. The drug was well tolerated up to 64 mg/kg. The main side effect was an unusual taste. No overt intoxication was seen. There was evidence for efficacy, with a significant reduction in tremor amplitude as measured by accelerometry and handwriting that was maximal at 2 hours. Higher doses may produce more sustained benefit.
引用
收藏
页码:2320 / 2322
页数:3
相关论文
共 10 条
[1]   ASSESSING TREMOR SEVERITY [J].
BAIN, PG ;
FINDLEY, LJ ;
ATCHISON, P ;
BEHARI, M ;
VIDAILHET, M ;
GRESTY, M ;
ROTHWELL, JC ;
THOMPSON, PD ;
MARSDEN, CD .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1993, 56 (08) :868-873
[2]   Pilot trial of 1-octanol in essential tremor [J].
Bushara, KO ;
Goldstein, SR ;
Grimes, GJ ;
Burstein, AH ;
Hallett, M .
NEUROLOGY, 2004, 62 (01) :122-124
[3]   NEUROPHYSIOLOGICAL STUDIES OF HARMALINE-INDUCED TREMOR IN CAT [J].
LAMARRE, Y ;
MERCIER, L .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1971, 49 (12) :1049-&
[4]   PHYSICOCHEMICAL CORRELATES OF ALCOHOL INTOXICATION [J].
MCCREERY, MJ ;
HUNT, WA .
NEUROPHARMACOLOGY, 1978, 17 (07) :451-461
[5]   ETHANOL EFFECTS ON HARMALINE-INDUCED TREMOR AND INCREASE OF CEREBELLAR CYCLIC-GMP [J].
RAPPAPORT, MS ;
GENTRY, RT ;
SCHNEIDER, DR ;
DOLE, VP .
LIFE SCIENCES, 1984, 34 (01) :49-56
[6]  
ROTHWELL JC, 1998, MOV DISORD S3, V13, pS24
[7]  
Shill HA, 2002, MOVEMENT DISORD, V17, pS346
[8]   ETHANOL EFFECTS ON THE OLIVOCEREBELLAR SYSTEM [J].
SINCLAIR, JG ;
LO, GF ;
HARRIS, DP .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1982, 60 (05) :610-614
[9]   THE EFFECTIVENESS OF DIFFERENT ISOMERS OF OCTANOL AS BLOCKERS OF HARMALINE-INDUCED TREMOR [J].
SINTON, CM ;
KROSSER, BI ;
WALTON, KD ;
LLINAS, RR .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1989, 414 (01) :31-36
[10]   A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials [J].
Thall, PF ;
Russell, KE .
BIOMETRICS, 1998, 54 (01) :251-264